ALDH2 and colorectal carcinoma: As a novel biological marker, ALDH2 is an attractive prospect in the screening, diagnosis, and evaluation of the prognosis of many diseases, and the genetic polymorphism of ALDH2 significantly correlated with the susceptibility to CRC (Li et al., 2016).